SCHEDULE: Fuller & Thaler Discloses 5.63% Stake in Conmed Corp
Beneficial Ownership Disclosure
Fuller & Thaler Asset Management, Inc. has disclosed a 5.63% beneficial ownership stake in Conmed Corp, totaling 1,740,630.07 common shares.
Summary
- Fuller & Thaler Asset Management, Inc. reported beneficial ownership of 1,740,630.07 shares of Conmed Corp common stock.
- This represents 5.63% of Conmed Corp's outstanding common stock.
- Fuller & Thaler Asset Management, Inc. holds sole voting power over 1,714,377.07 shares and sole dispositive power over 1,740,630.07 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Conmed Corp.
- Fuller & Thaler Asset Management, Inc. acts as an investment adviser for certain persons who have the right to receive dividends or proceeds from the sale of these securities.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of an ownership stake, which is neutral in sentiment regarding the company's performance. The presence of a significant institutional investor can be seen as a positive signal, but the filing itself does not contain performance data.
Positives
- A significant institutional investor, Fuller & Thaler Asset Management, Inc., has taken a substantial passive stake in Conmed Corp, potentially signaling confidence in the company's long-term prospects.
Negatives
- No specific negative information regarding Conmed Corp's operations or financial health is disclosed in this ownership filing.
Risks
- No specific risks related to Conmed Corp's operations or financial health are disclosed in this ownership filing. The filing itself is a disclosure of a passive investment.
Future Outlook
NA
Industry Context
This Schedule 13G filing indicates a significant passive investment by an asset management firm in Conmed Corp, a company operating in the medical technology and healthcare sector. Such filings are routine disclosures of substantial ownership stakes by institutional investors.
Stakeholder Impact
- Shareholders: Increased transparency regarding institutional ownership. The presence of a significant institutional investor might be viewed positively.
- Employees, Customers, Suppliers, Creditors: No direct impact from this ownership disclosure.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 08/14/2025 | Date of signature by Chief Compliance Officer |
Keywords
Conmed Corp, Fuller & Thaler Asset Management, Schedule 13G, Common Stock, Institutional Ownership, Investment Adviser, Medical Devices, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.